Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianna Fabbri

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Expert Review of Cardiovascular Therapy|October 27, 2012
A review of the epidemiological profile of patients with atrial fibrillation and heart failureGianna Fabbri, Aldo P Maggioni
Expert Opinion on Pharmacotherapy|March 30, 2005
VALIANT (VALsartan In Acute myocardial iNfarcTion) trialAldo Pietro Maggioni, Gianna Fabbri
Advances in Therapy|May 16, 2009
Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?Gianna Fabbri, Aldo Pietro Maggioni
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|February 27, 2004
[Ongoing trials and future prospects]Samuele Baldasseroni, Gianna Fabbri, Aldo Pietro Maggioni
Arrhythmia & Electrophysiology Review|February 3, 2016
Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?Francesco Orso, Gianna Fabbri, Aldo Pietro Maggioni
Handbook of Experimental Pharmacology|October 9, 2016
Epidemiology of Heart FailureFrancesco Orso, Gianna Fabbri, Aldo Pietro Maggioni
Giornale Italiano Di Cardiologia (2006)|November 2, 2007
[Heart failure: critical patients]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Heart failure: the importance of a disease management program]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Expert Opinion on Pharmacotherapy|July 4, 2014
Newest additions to heart failure treatmentFrancesco Orso, Gianna Fabbri, Samuele Baldasseroni, et al.
Giornale Italiano Di Cardiologia (2006)|April 4, 2007
[Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Expert Review of Cardiovascular Therapy|October 27, 2012
A review of the epidemiological profile of patients with atrial fibrillation and heart failureGianna Fabbri, Aldo P Maggioni
Expert Opinion on Pharmacotherapy|March 30, 2005
VALIANT (VALsartan In Acute myocardial iNfarcTion) trialAldo Pietro Maggioni, Gianna Fabbri
Advances in Therapy|May 16, 2009
Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?Gianna Fabbri, Aldo Pietro Maggioni
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|February 27, 2004
[Ongoing trials and future prospects]Samuele Baldasseroni, Gianna Fabbri, Aldo Pietro Maggioni
Arrhythmia & Electrophysiology Review|February 3, 2016
Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?Francesco Orso, Gianna Fabbri, Aldo Pietro Maggioni
Handbook of Experimental Pharmacology|October 9, 2016
Epidemiology of Heart FailureFrancesco Orso, Gianna Fabbri, Aldo Pietro Maggioni
Giornale Italiano Di Cardiologia (2006)|November 2, 2007
[Heart failure: critical patients]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Heart failure: the importance of a disease management program]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Expert Opinion on Pharmacotherapy|July 4, 2014
Newest additions to heart failure treatmentFrancesco Orso, Gianna Fabbri, Samuele Baldasseroni, et al.
Giornale Italiano Di Cardiologia (2006)|April 4, 2007
[Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]Gianna Fabbri, Marco Gorini, Aldo P Maggioni, et al.
Pageof 4